• James Cox, MD, has been named medical director of ATS Medical (Minneapolis), a manufacturer of cardiac surgery products and services.

• Ali Haghighi-Mood, PhD, has been promoted to CEO of Cambridge Heart (Bedford, Massachusetts). Most recently, he has served as executive VP, COO and chief technology officer of the company since December 2006. Cambridge Heart makes products for the non-invasive diagnosis of cardiac disease, particularly the identification of those at risk of sudden cardiac arrest.

• Patricia Knipper, RN, has been named VP of global marketing development of Coherex Medical (Salt Lake City). Knipper previously worked at the Cardiovascular Research Foundation. Coherex developing technologies to treat structural heart disease and conditions.

Escalon Medical (Wayne, Pennsylvania) reported two executive management promotions. Richard DePiano Jr. has been promoted to president, and Mark Wallace has been promoted to COO. DePiano joined Escalon in 2003 and most recently served as COO and general counsel. Wallace joined Escalon in 1997, serving most recently as executive VP. Escalon makes vascular access devices and ophthalmic diagnostic and surgical products.

• Christopher Barys has been named senior VP of sales for FlowCardia (Sunnyvale, California). Barys served as VP of sales and marketing for the peripheral vascular systems business of Edwards Lifesciences. FlowCardia makes endovascular devices for coronary and peripheral chronic total occlusion recanalization.

• Barry Wilson has been elected to serve as independent director and chairman of the board of Heartscape Technologies (Columbia, Maryland), which makes an FDA-approved device that diagnoses heart attacks and ischemia.

• Scot Dube has been named vice president of sales at InterCure (New York), manufacturer of the Resperate hypertension treatment device.

TherOx (Irvine, California) reported that Shelley Thunen has been named CFO. Most recently, Thunen served as executive VP and CFO of IntraLase. TherOx is focused on developing its Supersaturated Oxygen Therapy designed to salvage heart muscle in acute heart attack patients.

No Comments